Author:
Lin Yu, ,Yang Chao,Chu Hong,Wu Jingyi,Lin Ke,Shi Ying,Wang Haibo,Kong Guilan,Zhang Luxia
Abstract
Abstract
Background
Patients receiving maintenance hemodialysis (HD) and peritoneal dialysis (PD) are frequently hospitalized. Reducing unplanned 30-day hospital readmissions is a key priority for improving the quality of health care. The purpose of this study was to assess the association between the Charlson Comorbidity Index (CCI), which has been used to evaluate multi-comorbidities status, and 30-day readmission in patients on HD and PD therapy.
Methods
The Hospital Quality Monitoring System (HQMS), a national administrative database for hospitalized patients in China was used to extract dialysis patients admitted from January 2013 to December 2015. The outcome was the unplanned readmission following the hospital discharge within 30 days. For patients with multiple hospitalizations, a single hospitalization was randomly selected as the index hospitalization. A cause-specific Cox proportional hazard model was utilized to assess the association of CCI with readmission within 30 days.
Results
Of the 124,721 patients included in the study, 19,893 patients (16.0%) were identified as experiencing unplanned readmissions within 30 days. Compared with patients without comorbidity (CCI = 2, scored for dialysis), the risk of 30-day readmission increased with elevated CCI score. The hazards ratio (HR) for those with CCI 3–4, 5–6 and > 6 was 1.01 (95% confidence interval [CI] 0.98–1.05), 1.09 (95% CI 1.05–1.14), and 1.14 (95% CI 1.09–1.20), respectively.
Conclusions
Our study indicated that CCI was independently associated with the risk of 30-day readmission for patients receiving dialysis including HD and PD, and could be used for risk-stratification.
Funder
National Natural Science Foundation of China
Grants from Peking University
the National Key Technology R&D Program of the Ministry of Science and Technology of the People's Republic of China
the University of Michigan Health System-Peking University Health Science Center Joint Institute for Translational and Clinical Research
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.
2. Saran R, Robinson B, Abbott KC, Agodoa LYC, Bhave N, Bragg-Gresham J, et al. US renal data dystem 2017 annual data report: Epidemiology of kidney disease in the United States. Am J Kidney Dis. 2018;71(3S1):A7.
3. Fishbane S, Wish JB. Quality measurement in Wonderland: The curious case of a dialysis readmissions measure. Clin J Am Soc Nephrol. 2016;11(1):190–4.
4. US Government Printing Office. Federal Register. In: U.S. Government Publishing Office.
https://www.gpo.gov/fdsys/pkg/FR-2014-11-06/pdf/2014–26182.pdf
; Accessed 12 Jan 2015.
5. Hakim RM, Collins AJ. Reducing avoidable rehospitalization in ESRD: a shared accountability. J Am Soc Nephrol. 2014;25(9):1891–3.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献